Sovereign wealth funds investing in healthcare and life sciences in Asia

This page lists 18 sovereign wealth funds investing in healthcare and life sciences in Asia. The list includes reserve investment corporations, state holding companies, strategic development funds, pension reserve funds, and a savings fund. Featured institutions include China Investment Corporation, GIC Private Limited, Temasek Holdings, and Japan Investment Corporation.

Largest funds on this list by reported size, USD bnLargest funds on this list by reported size, USD bnCIC1,567GIC1,160Exchange Fund572NSSF544Temasek401KIC232PNB90Samruk-Kazyna88NDF64Khazanah38Future Fund30JIC17Latest figure on each profile. Estimates are labelled in the table below. Source: fund profiles on SovereignWealthFunds.com.

The 18 funds

#FundCountryReported sizeIn US dollarsTypeOur transparency score
1China Investment CorporationChinaUSD 1,567B, as of December 9, 2025[1][2]USD 1.57TReserve investment corporation8 of 10
2GIC Private LimitedSingaporeAbout USD 1.16T Estimate, as of March 31, 2026[3]USD 1.16TReserve investment corporation7 of 10
3Hong Kong Monetary Authority Exchange FundHong Kong SAR, ChinaHKD 4,463.6B, as of June 30, 2026[4]USD 572.0BReserve investment corporation8 of 10
4National Council for Social Security Fund (NSSF)ChinaRMB 3,808B, as of December 31, 2025[5][6]USD 544.0BPension reserve fund8 of 10
5Temasek HoldingsSingaporeS$518B, as of July 8, 2026[7][8]USD 401.0BState holding company10 of 10
6Korea Investment CorporationSouth KoreaUSD 232.0B, as of December 31, 2025[9]USD 232.0BReserve investment corporation8.5 of 10
7Permodalan Nasional Berhad (PNB)MalaysiaRM365.3B, as of December 31, 2025[10][11]USD 90.1BState holding company8.5 of 10
8Samruk-Kazyna JSCKazakhstanKZT 44.2T, as of December 31, 2025[12]USD 87.5BState holding company8.5 of 10
9National Development Fund (Taiwan)TaiwanNT$2,098.5B, as of December 31, 2024[13]USD 64.0BStrategic development fund8 of 10
10Khazanah Nasional BerhadMalaysiaRM156B, as of July 9, 2026[14][15][16]USD 38.4BState holding company9 of 10
11Hong Kong Future FundHong Kong SAR, ChinaHK$235.1B, as of January 28, 2026[17]USD 30.2BSavings and future generations fund4 of 10
12Japan Investment Corporation (JIC)JapanJPY 2.60T, as of March 31, 2026[18]USD 16.6BStrategic development fund6.5 of 10
13Tamilnadu Industrial Development Corporation Ltd (TIDCO)IndiaINR 103,607 crore, as of December 31, 2025[19][20]USD 11.5BState holding company5 of 10
14Hong Kong Investment Corporation (HKIC)Hong Kong SAR, ChinaHK$62B, as of October 5, 2026[21]USD 8.0BStrategic development fund6 of 10
15Indonesia Investment AuthorityIndonesiaRp111.0tn, as of December 31, 2025[22][23]USD 6.6BStrategic development fund9 of 10
16National Investment and Infrastructure Fund (NIIF), IndiaIndiaUSD 5B+, as of June 29, 2026[24]USD 5.0BStrategic development fund6 of 10
17Armed Forces Fund BoardMalaysiaRM13.36B, as of March 12, 2026[25]USD 3.3BPension reserve fund5.5 of 10
18State Capital Investment CorporationVietnamVND 72,474bn total assets (end 2025), as of July 1, 2026[26][11]USD 2.8BState holding company8.5 of 10

Patterns in this list

  • The funds are based across Asia, including China, Singapore, Hong Kong, South Korea, Malaysia, Kazakhstan, Taiwan, Japan, India, Indonesia, and Vietnam.
  • Fund structures include reserve investment corporations, state holding companies, strategic development funds, pension reserve funds, and savings funds.
  • Investment approaches range from direct stakes and joint ventures to external manager mandates, venture fund commitments, and co-investments.

How we built this list

This list includes every operating fund in our 231 fund profiles that matches on the focus sectors field and is based in Asia. Funds are ordered by their latest reported size in US dollars, shown in its own column next to the size in the currency each fund reports. Each profile shows the document and date behind every figure, and estimates carry an Estimate label.

See all funds in the region: Asia sovereign wealth funds

Frequently asked questions

Which Asian sovereign funds allocate to life sciences through venture capital and private equity funds?

Japan Investment Corporation commits capital to private general partners, and National Development Fund in Taiwan has backed 117 venture capital funds. Hong Kong Investment Corporation, Temasek Holdings, and National Investment and Infrastructure Fund also use private equity or venture capital formats.

Do these sovereign wealth funds co-invest in healthcare alongside external partners?

Yes. GIC Private Limited, Temasek Holdings, Indonesia Investment Authority, and Permodalan Nasional Berhad regularly co-invest with general partners and operating companies. National Investment and Infrastructure Fund and China Investment Corporation also take direct co-investment positions.

Which state holding companies on this list hold direct assets in pharmaceuticals and healthcare?

State Capital Investment Corporation in Vietnam, Armed Forces Fund Board and Permodalan Nasional Berhad in Malaysia, and Tamilnadu Industrial Development Corporation Ltd in India all hold direct interests in pharmaceuticals or healthcare companies.

Sources
  1. CIC, Annual Report 2024, as of December 9, 2025
  2. CIC, release on the 2024 annual report (Chinese), as of December 9, 2025
  3. Reuters, GIC results and hedge fund plan, 23 July 2026, as of July 24, 2026
  4. HKMA, Exchange Fund position at end of June 2026, press release, as of July 28, 2026
  5. Securities Times, NSSF annual report 2025 figures (Chinese), as of September 2, 2026
  6. ECB reference rate via Frankfurter, USD/CNY on 31 December 2025, as of December 31, 2025
  7. Temasek, Temasek Review 2026 press release, 8 July 2026, as of July 8, 2026
  8. Temasek Review 2026, Performance and portfolio, as of March 31, 2026
  9. KIC Annual Report 2025, performance overview, as of December 31, 2025
  10. PNB, Integrated Annual Report 2025, as of December 31, 2025
  11. Currency API, US dollar rates at 31 December 2025, as of December 31, 2025
  12. Samruk-Kazyna, Annual Report 2025 with audited IFRS statements, as of December 31, 2025
  13. National Development Fund, annual report 2024 (Chinese), as of December 31, 2024
  14. Khazanah, Laporan Khazanah 2025 (Malay), as of July 9, 2026
  15. Khazanah, Annual Review 2026 presentation, as of February 10, 2026
  16. Frankfurter, USD to MYR reference rate for 31 December 2025, as of December 31, 2025
  17. HKMA, Exchange Fund results for 2025, 28 January 2026, as of January 28, 2026
  18. JIC, investment record, as of March 31, 2026
  19. CARE Ratings, TIDCO rating rationale, April 2026, as of April 13, 2026
  20. Frankfurter, USD to INR rate on 31 December 2025, as of December 31, 2025
  21. Hong Kong Investment Corporation, Home, as of October 5, 2026
  22. INA, Annual Report 2025, as of December 31, 2025
  23. Frankfurter (ECB reference rates), 31 December 2025, as of December 31, 2025
  24. NIIF, Government approves additional INR 30,000 crore allocation, as of June 29, 2026
  25. The Edge Malaysia, LTAT FY2025 dividend and liquid assets, as of March 12, 2026
  26. Nguoi Quan Sat, inside SCIC capital and dividends, as of July 1, 2026

Talk to Richard

Richard C. Wilson founded the Family Office Club and publishes SovereignWealthFunds.com. If you are a fund manager, capital raiser or family office and want to talk through sovereign wealth funds investing in healthcare and life sciences in Asia, reach out to him directly.

Disclaimer

Informational only. SovereignWealthFunds.com is an independent public-source reference. It is not affiliated with or endorsed by any fund named on it, and it is not investment, legal or tax advice. Figures are as of the dates shown next to them and may have changed; please read each fund's official pages, linked on its profile. To report an error, use the contact page. Copyright SovereignWealthFunds.com. All rights reserved.